Male Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01355393Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast CancerTreatment
NCT00791037Vaccine Therapy in Treating Patients With Stage IV Breast CancerTreatment